Schonfeld Strategic Advisors LLC Sarepta Therapeutics, Inc. Transaction History

Schonfeld Strategic Advisors LLC

$15.4 Billion
Q4 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 49,410 shares of SRPT stock, worth $4.93 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

49,410

Previous 61,362 19.48%

Holding current value

$4.93 Million

Previous $7.66 Million 21.62%

% of portfolio

0.04%

Previous 0.06%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$104.54 - $137.94 $1.25 Million - $1.65 Million	-11,952 Reduced 19.48%	49,410 $6.01 Million
Q3 2024 Nov 14, 2024	BUY	$124.33 - $156.75 $5.8 Million - $7.31 Million	46,647 Added 317.0%	61,362 $7.66 Million
Q2 2024 Aug 14, 2024	BUY	$113.33 - $163.85 $1.67 Million - $2.41 Million	14,715 New	14,715 $2.32 Million
Q4 2023 Feb 14, 2024	SELL	$67.31 - $124.76 $3.98 Million - $7.37 Million	-59,107 Reduced 65.15%	31,618 $3.05 Million
Q3 2023 Nov 14, 2023	BUY	$102.5 - $123.59 $77,182 - $93,063	753 Added 0.84%	90,725 $11 Million
Q2 2023 Aug 14, 2023	BUY	$106.4 - $157.19 $8.28 Million - $12.2 Million	77,809 Added 639.72%	89,972 $10.3 Million
Q1 2023 May 15, 2023	SELL	$117.53 - $155.99 $15.7 Million - $20.8 Million	-133,628 Reduced 91.66%	12,163 $1.68 Million
Q4 2022 Feb 14, 2023	BUY	$100.86 - $132.13 $7.58 Million - $9.93 Million	75,175 Added 106.46%	145,791 $18.9 Million
Q3 2022 Nov 14, 2022	SELL	$75.71 - $119.24 $150,360 - $236,810	-1,986 Reduced 2.74%	70,616 $7.81 Million
Q2 2022 Aug 15, 2022	BUY	$62.69 - $88.44 $2.44 Million - $3.44 Million	38,937 Added 115.66%	72,602 $5.44 Million
Q1 2022 May 16, 2022	SELL	$63.15 - $90.42 $444,260 - $636,104	-7,035 Reduced 17.29%	33,665 $2.63 Million
Q4 2021 Feb 14, 2022	BUY	$77.28 - $99.42 $3.15 Million - $4.05 Million	40,700 New	40,700 $3.67 Million
Q3 2021 Nov 16, 2021	SELL	$65.97 - $92.48 $216,579 - $303,611	-3,283 Closed	0 $0
Q2 2021 Nov 16, 2021	SELL	$69.38 - $86.75 $360,776 - $451,100	-5,200 Reduced 61.3%	3,283 $255,000
Q2 2021 Aug 16, 2021	SELL	$69.38 - $86.75 $91,442 - $114,336	-1,318 Reduced 13.45%	8,483 $659,000
Q1 2021 May 17, 2021	BUY	$72.25 - $168.95 $432,922 - $1.01 Million	5,992 Added 157.31%	9,801 $731,000
Q4 2020 Feb 16, 2021	SELL	$125.56 - $178.74 $337,881 - $480,989	-2,691 Reduced 41.4%	3,809 $649,000
Q3 2020 Nov 16, 2020	BUY	$127.12 - $172.34 $826,280 - $1.12 Million	6,500 New	6,500 $1,000
Q1 2020 May 15, 2020	SELL	$82.38 - $131.64 $374,005 - $597,645	-4,540 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$76.53 - $135.58 $7.51 Million - $13.3 Million	-98,160 Reduced 95.58%	4,540 $586,000
Q3 2019 Nov 14, 2019	SELL	$72.81 - $156.91 $1.24 Million - $2.67 Million	-17,000 Reduced 14.2%	102,700 $7.74 Million
Q2 2019 Aug 14, 2019	BUY	$112.21 - $151.95 $13.4 Million - $18.2 Million	119,700 New	119,700 $18.2 Million
Q4 2018 Feb 14, 2019	SELL	$97.32 - $148.76 $6.7 Million - $10.2 Million	-68,800 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$115.31 - $161.51 $3.26 Million - $4.57 Million	-28,300 Reduced 29.15%	68,800 $11.1 Million
Q2 2018 Aug 14, 2018	BUY	$71.74 - $153.69 $6.34 Million - $13.6 Million	88,438 Added 1020.99%	97,100 $12.8 Million
Q1 2018 May 15, 2018	SELL	$54.02 - $82.27 $4.39 Million - $6.69 Million	-81,338 Reduced 90.38%	8,662 $641,000
Q4 2017 Feb 14, 2018	SELL	$47.64 - $56.75 $5.23 Million - $6.23 Million	-109,789 Reduced 54.95%	90,000 $5.01 Million
Q3 2017 Nov 14, 2017	BUY	$35.73 - $47.15 $7.14 Million - $9.42 Million	199,789	199,789 $9.06 Million

Others Institutions Holding SRPT

# of Institutions

536

Shares Held

87.4M

Call Options Held

1.55M

Put Options Held

1.35M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $8.73B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Sarepta Therapeutics, Inc. Transaction History